Sherry â€" Shown to have Health BenefitsMarch 17, 2004New research published in Journal of the Science of Food and Agriculture suggests that sherry may have the same health benefits as red wine. Sherry contains antioxidants that help control cholesterol levels, say Spanish scientists. Studies by researchers at University of Seville have shown that sherry, like red wine, contains antioxidants called polyphenols, which reduce the occurrence of coronary artery disease. They work by preventing the oxidation of Low-Density Lipoproteins (LDL), which is associated with the disease. Drinking sherry can also increase the body's production of High-Density Lipoprotein (HDL) cholesterol, which is associated with longevity and a decreased incidence of coronary artery disease. 'Sherry is widely consumed, especially in Spain and the UK, and we have shown that its moderate intake decreased total cholesterol and increased HDL-cholesterol,' says Juan M. Guerrero, researcher on the paper. To test the effects, rats were given daily quantities of sherry equivalent of a 150ml serving in an adult weighing 70kg. Control rats were given the same amount of either water or ethanol in water. Intake of sherry every day at 16:00 over two months did not affect the weight of the rats or have any other significant impact on other metabolic processes - but it did result in the decrease in serum total (bad) cholesterol and an increase in HDL (good) cholesterol. Four of the most commonly produced sherries in Andalucia, Spain, bearing the generic names Oloroso, Manzanilla, Fino and Amontillado, were tested. All four types had the same effect. 'As a general rule, moderate consumption of red wine exerts beneficial effects for health. In our research, the beneficial effects of red wine can be extensive to sherry wines,' says Guerrero. Society of Chemical Industry |
|||||||||||||||||||||
| Related Cholesterol Current Events and Cholesterol News Articles Genetic analysis helps dissect molecular basis of cardiovascular disease Using highly precise measurements of plasma lipoprotein concentrations determined by nuclear magnetic resonance spectroscopy (NMR), researchers led by Daniel Chasman at Brigham and Women's Hospital and Harvard Medical School in Boston, MA, the Framingham Heart Study in Framingham, and the PROCARDIS consortium in Stockholm, Sweden and Oxford, England performed genetic association analysis across the whole genome among 17,296 women of European ancestry from the Women's Genome Health Study. New understanding about mechanism for cell death after stroke leads to possible therapy Scientists at the Brain Research Centre, a partnership of the University of British Columbia Faculty of Medicine and Vancouver Coastal Health Research Institute, have uncovered new information about the mechanism by which brain cells die following a stroke, as well as a possible way to mitigate that damage. Dispensing prescription drugs in 3-month supplies reduces drug costs by a third Purchasing prescription drugs in a three-month supply rather than a one-month supply has long been regarded as a way to reduce the cost of drugs for patients and third-party payers. New research from the University of Chicago quantifies the savings for the first time. The Protein Srebp2 Drives Cholesterol Formation in Prion-Infected Neuronal Cells Which May Promote Prion-Dependent Diseases The regulating protein Srebp2 drives cholesterol formation, which prions need for their propagation, in prion-infected neuronal cells. Pivotal study for PSD502 -- the first potential treatment for premature ejaculation At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE)., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE). Night Beat, Overtime and a Disrupted Sleep Pattern Can Harm Officers' Health A police officer who works the night shift, typically from 8 p.m. to 4 a.m., already is at a disadvantage when it comes to getting a good "night's" sleep. Vitamin B niacin offers no extra benefit to statin therapy in seniors already diagnosed with CAD The routine prescription of extended-release niacin, a B vitamin (1,500 milligrams daily), in combination with traditional cholesterol-lowering therapy offers no extra benefit in correcting arterial narrowing and diminishing plaque buildup in seniors who already have coronary artery disease, a new vascular imaging study from Johns Hopkins experts shows. Heart and bone damage from low vitamin D tied to declines in sex hormones Researchers at Johns Hopkins are reporting what is believed to be the first conclusive evidence in men that the long-term ill effects of vitamin D deficiency are amplified by lower levels of the key sex hormone estrogen, but not testosterone. Early end to key study on benefits of niacin, a B vitamin, in keeping arteries open was premature Heart experts at Johns Hopkins are calling premature the early halt of a study by researchers at Walter Reed Army Medical Center and Washington Hospital Center on the benefits of combining extended-release niacin, a B vitamin, with cholesterol-lowering statin medications to prevent blood vessel narrowing. oo much selenium can increase your cholesterol A new study from the University of Warwick has discovered taking too much of the essential mineral selenium in your diet can increase your cholesterol by almost 10%. More Cholesterol Current Events and Cholesterol News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||